Market Overview - U.S. stocks experienced an upward trend, with the Nasdaq Composite increasing by 1% on Friday [1] - The Dow Jones rose by 0.80% to 47,108.01, while the S&P 500 gained 0.83% to 6,794.12 [1] - Information technology shares saw a notable increase of 1.3%, while materials stocks declined by 0.3% [1] Company Performance - Procter & Gamble Co. reported better-than-expected earnings per share (EPS) of $1.99 for Q3, a 3% increase year-over-year, surpassing the analyst consensus of $1.90 [2] - The company's quarterly sales reached $22.386 billion, exceeding the expected $22.175 billion [2] - Procter & Gamble raised its fiscal 2026 adjusted EPS guidance to a range of $6.83-$7.10, compared to the previous range of $6.83-$7.09 and above the analyst estimate of $6.97 [3] - The sales outlook for fiscal 2026 was adjusted to $85.127 billion-$88.498 billion, slightly up from the previous range and below the expected $86.919 billion [3] Stock Movements - Wellgistics Health, Inc. shares surged by 183% to $1.17 following a non-binding letter of intent with Datavault AI Inc. [8] - Genenta Science S.p.A. saw its shares increase by 145% to $7.93 due to an expanded collaboration with ANEMOCYTE [8] - Neuphoria Therapeutics Inc. shares rose by 89% to $7.61 after a significant share purchase by a shareholder [8] - Conversely, Picard Medical, Inc. shares dropped by 72% to $3.67, and MultiSensor AI Holdings, Inc. shares fell by 46% to $0.7304 after announcing a private placement [8] Economic Indicators - The S&P Global services PMI increased to 55.2 in October from 54.2 in September, surpassing market expectations of 53.5 [11] - The S&P Global manufacturing PMI rose to 52.2 in October from 52.0, exceeding estimates of 52.0 [11] - The S&P Global composite PMI jumped to 54.8 in October from 53.9 in September [11]
Nasdaq Surges 1%; Procter & Gamble Posts Upbeat Earnings